Wordt geladen...
Morning for irofulven, what could be fiNER?
Cancers with DNA repair dysfunction are vulnerable to DNA damaging agents that that invoke a requirement for the disabled repair mechanism. Genome sequencing, coupled with a detailed understanding of mechanisms of DNA repair, has accelerated the discovery of pathway-selective agents that target DNA...
Bewaard in:
| Gepubliceerd in: | Clin Cancer Res |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8026716/ https://ncbi.nlm.nih.gov/pubmed/33472911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-4708 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|